The 3 references without contexts in paper G. Gorodetskaya I., V. Kukes G., S. Belkov A., R. Kazakov E., S. Serebrova Yu., O. Muslimova V., T. Rodina A., A. Aleksandrov A., Г. Городецкая И., В. Кукес Г., С. Белков А., Р. Казаков Е., С. Сереброва Ю., О. Муслимова В., Т. Родина А., А. Александров А. (2018) “Фармакогенетическое тестирование в оптимизации терапии сахарного диабета 2 типа препаратами сульфонилмочевины // Pharmacogenetic testing in the treatment of type 2 diabetes with sulfonylurea drugs” / spz:neicon:vedomostincesmp:y:2017:i:4:p:233-241

47
Scientific substantiation, development and improvement of methodology for assessment of medicinal products interchangeability. Research report (intermediate). FSBI «SCEEMP» of the Ministry of Health of Russia; advisors: Romanov BK, Prokofiev AB, Yagudina RI; prepared by: Alyautdin RN, Zhuravleva MV. Moscow; 2016. 365 p. No. SR 115111740009. Deposited in CITIS on 26.01.2017, No. IKRBS 217012640056-0 (in Russian).
(check this in PDF content)
48
Bukatina TM, Kazakov AS, Velts NYu, Darmostukova MA, Kolesnikova EYu, Alyautdin RN, et al. Inhibitors of sodium-glucose cotransporter 2: risk of ketoacidosis. Safety and Risk of Pharmacotherapy 2016; (2): 33–9.
(check this in PDF content)
49
Chuchalin AG, Hohlov AL, eds. Federal guidance on the use of drugs (formulary system). Issue XVIII. Moscow: Vidoks; 2017 (in Russian). AUTHORS Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation, Petrovsky boulevard 8, bld. 2, Moscow 127051, Russian Federation.
(check this in PDF content)